Skip to main content

apoptosis

Slowing ALS with a Two-Drug Therapy

Results from a phase 2 clinical trial reveal that a new two-drug therapy for ALS can slow disease progression by six weeks over a six-month period. This therapy could possibly improve lifespan and quality of life, and may be effective in other…

Cell Fate

As humans, we are aware that we are committed to a certain fate: we are born, we live, and we inevitably die. We are less aware that each of the trillion cells in our bodies also have a fate of their own, and everyday each cell has to decide whether to…